Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Harvoni

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.

Gilead gets OK for three-in-one hep C therapy in US

Gilead gets OK for three-in-one hep C therapy in US Sovaldi and follow-ups Harvoni and Epclusa are still pulling in big bucks for Gilead - adding $2.6bn to its revenues in the first quarter of this year - but were down

Samsung Bioepis wins CHMP nod for second Humira biosimilar

Samsung Bioepis wins CHMP nod for second Humira biosimilar Both were reviewed under the accelerated assessment protocol because despite the robust efficacy of current drugs such as Gilead's Harvoni (sofosbuvir/ledipasvir) and AbbVie's Viekira (ombitasvir/paritaprevir/ritonavir and

Two new hepatitis C therapies fast-tracked in Europe

Two new hepatitis C therapies fast-tracked in Europe Sofosbuvir and velpatasvir are the two active ingredients in Gilead's recently-approved two-drug HCV combination Epclusa, as a successor to its massively successful Harvoni (sofosbuvir/ledipasvir) but with activity ... Analysts at Leerink have previously

The future of biotech

The future of biotech IMS data for 2015 highlighted that six out of ten of the world's best-selling medicines were biologics: $18bn for Harvoni, a new medicine; $15bn for Humira and $6bn for

Global drug spending will rise by a third to $1.5trn in 2021

Global drug spending will rise by a third to $1.5trn in 2021 The uptick stemmed from the launched of new drugs for hepatitis C such as Gilead's Sovaldi and Harvoni as well as new cancer medicines, but the impact of these will

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics